May 6, 2020
Dr. David Artis, Director of the Jill Roberts Institute for Research in Inflammatory Bowel Disease, and team have published a paper in Immunity that reveals a critical new finding regarding the Tph1 gene and ILC2 (allergy linked immune cells). The study found that ramped-up production of Tph1 helps ILC2s to enter an inflammatory state. This advance may lead to future drugs that could suppress Tph1 in an attempt to alleviate allergic and inflammatory conditions.